Cargando…

A Novel Program to Provide Drug Recovery Assistance and Outpatient Parenteral Antibiotic Therapy in People Who Inject Drugs

BACKGROUND: Safe hospital discharge on parenteral antibiotic therapy is challenging for people who inject drugs (PWID) admitted with serious bacterial infections (SBI). We describe a Comprehensive Care of Drug Addiction and Infection (CCDAI) program involving a partnership between Intermountain Heal...

Descripción completa

Detalles Bibliográficos
Autores principales: Gelman, Stephanie S, Stenehjem, Eddie, Foster, Rachel A, Tinker, Nick, Grisel, Nancy, Webb, Brandon J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801220/
https://www.ncbi.nlm.nih.gov/pubmed/35106314
http://dx.doi.org/10.1093/ofid/ofab629
_version_ 1784642405610291200
author Gelman, Stephanie S
Stenehjem, Eddie
Foster, Rachel A
Tinker, Nick
Grisel, Nancy
Webb, Brandon J
author_facet Gelman, Stephanie S
Stenehjem, Eddie
Foster, Rachel A
Tinker, Nick
Grisel, Nancy
Webb, Brandon J
author_sort Gelman, Stephanie S
collection PubMed
description BACKGROUND: Safe hospital discharge on parenteral antibiotic therapy is challenging for people who inject drugs (PWID) admitted with serious bacterial infections (SBI). We describe a Comprehensive Care of Drug Addiction and Infection (CCDAI) program involving a partnership between Intermountain Healthcare hospitals and a detoxification facility (DF) to provide simultaneous drug recovery assistance and parenteral antibiotic therapy (DRA-OPAT). METHODS: The CCDAI program was evaluated using a pre-/poststudy design. We compared outcomes in PWID hospitalized with SBI during a 1-year postimplementation period (2018) with similar patients from a historical control period (2017), identified by propensity modeling and manual review. RESULTS: Eighty-seven patients were candidates for the CCDAI program in the implementation period. Thirty-five participants (40.2%) enrolled in DRA-OPAT and discharged to the DF; 16 (45.7%) completed the full outpatient parenteral antibiotic therapy (OPAT) duration. Fifty-one patients with similar characteristics were identified as a preimplementation control group. Median length of stay (LOS) was reduced from 22.9 days (interquartile interval [IQI], 9.8–42.7) to 10.6 days (IQI, 6–17.4) after program implementation (P < .0001). Total median cost decreased from $39 220.90 (IQI, $23 300.71–$82 506.66) preimplementation to $27 592.39 (IQI, $18 509.45–$48 369.11) postimplementation (P < .0001). Ninety-day readmission rates were similar (23.5% vs 24.1%; P = .8). At 1-year follow-up, all-cause mortality was 7.1% in the preimplementation group versus 1.2% postimplementation (P = .06). CONCLUSIONS: Partnerships between hospitals and community resources hold promise for providing resource-efficient OPAT and drug recovery assistance. We observed significant reductions in LOS and cost without increases in readmission rates; 1-year mortality may have been improved. Further study is needed to optimize benefits of the program.
format Online
Article
Text
id pubmed-8801220
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-88012202022-01-31 A Novel Program to Provide Drug Recovery Assistance and Outpatient Parenteral Antibiotic Therapy in People Who Inject Drugs Gelman, Stephanie S Stenehjem, Eddie Foster, Rachel A Tinker, Nick Grisel, Nancy Webb, Brandon J Open Forum Infect Dis Major Article BACKGROUND: Safe hospital discharge on parenteral antibiotic therapy is challenging for people who inject drugs (PWID) admitted with serious bacterial infections (SBI). We describe a Comprehensive Care of Drug Addiction and Infection (CCDAI) program involving a partnership between Intermountain Healthcare hospitals and a detoxification facility (DF) to provide simultaneous drug recovery assistance and parenteral antibiotic therapy (DRA-OPAT). METHODS: The CCDAI program was evaluated using a pre-/poststudy design. We compared outcomes in PWID hospitalized with SBI during a 1-year postimplementation period (2018) with similar patients from a historical control period (2017), identified by propensity modeling and manual review. RESULTS: Eighty-seven patients were candidates for the CCDAI program in the implementation period. Thirty-five participants (40.2%) enrolled in DRA-OPAT and discharged to the DF; 16 (45.7%) completed the full outpatient parenteral antibiotic therapy (OPAT) duration. Fifty-one patients with similar characteristics were identified as a preimplementation control group. Median length of stay (LOS) was reduced from 22.9 days (interquartile interval [IQI], 9.8–42.7) to 10.6 days (IQI, 6–17.4) after program implementation (P < .0001). Total median cost decreased from $39 220.90 (IQI, $23 300.71–$82 506.66) preimplementation to $27 592.39 (IQI, $18 509.45–$48 369.11) postimplementation (P < .0001). Ninety-day readmission rates were similar (23.5% vs 24.1%; P = .8). At 1-year follow-up, all-cause mortality was 7.1% in the preimplementation group versus 1.2% postimplementation (P = .06). CONCLUSIONS: Partnerships between hospitals and community resources hold promise for providing resource-efficient OPAT and drug recovery assistance. We observed significant reductions in LOS and cost without increases in readmission rates; 1-year mortality may have been improved. Further study is needed to optimize benefits of the program. Oxford University Press 2021-12-10 /pmc/articles/PMC8801220/ /pubmed/35106314 http://dx.doi.org/10.1093/ofid/ofab629 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Major Article
Gelman, Stephanie S
Stenehjem, Eddie
Foster, Rachel A
Tinker, Nick
Grisel, Nancy
Webb, Brandon J
A Novel Program to Provide Drug Recovery Assistance and Outpatient Parenteral Antibiotic Therapy in People Who Inject Drugs
title A Novel Program to Provide Drug Recovery Assistance and Outpatient Parenteral Antibiotic Therapy in People Who Inject Drugs
title_full A Novel Program to Provide Drug Recovery Assistance and Outpatient Parenteral Antibiotic Therapy in People Who Inject Drugs
title_fullStr A Novel Program to Provide Drug Recovery Assistance and Outpatient Parenteral Antibiotic Therapy in People Who Inject Drugs
title_full_unstemmed A Novel Program to Provide Drug Recovery Assistance and Outpatient Parenteral Antibiotic Therapy in People Who Inject Drugs
title_short A Novel Program to Provide Drug Recovery Assistance and Outpatient Parenteral Antibiotic Therapy in People Who Inject Drugs
title_sort novel program to provide drug recovery assistance and outpatient parenteral antibiotic therapy in people who inject drugs
topic Major Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801220/
https://www.ncbi.nlm.nih.gov/pubmed/35106314
http://dx.doi.org/10.1093/ofid/ofab629
work_keys_str_mv AT gelmanstephanies anovelprogramtoprovidedrugrecoveryassistanceandoutpatientparenteralantibiotictherapyinpeoplewhoinjectdrugs
AT stenehjemeddie anovelprogramtoprovidedrugrecoveryassistanceandoutpatientparenteralantibiotictherapyinpeoplewhoinjectdrugs
AT fosterrachela anovelprogramtoprovidedrugrecoveryassistanceandoutpatientparenteralantibiotictherapyinpeoplewhoinjectdrugs
AT tinkernick anovelprogramtoprovidedrugrecoveryassistanceandoutpatientparenteralantibiotictherapyinpeoplewhoinjectdrugs
AT griselnancy anovelprogramtoprovidedrugrecoveryassistanceandoutpatientparenteralantibiotictherapyinpeoplewhoinjectdrugs
AT webbbrandonj anovelprogramtoprovidedrugrecoveryassistanceandoutpatientparenteralantibiotictherapyinpeoplewhoinjectdrugs
AT gelmanstephanies novelprogramtoprovidedrugrecoveryassistanceandoutpatientparenteralantibiotictherapyinpeoplewhoinjectdrugs
AT stenehjemeddie novelprogramtoprovidedrugrecoveryassistanceandoutpatientparenteralantibiotictherapyinpeoplewhoinjectdrugs
AT fosterrachela novelprogramtoprovidedrugrecoveryassistanceandoutpatientparenteralantibiotictherapyinpeoplewhoinjectdrugs
AT tinkernick novelprogramtoprovidedrugrecoveryassistanceandoutpatientparenteralantibiotictherapyinpeoplewhoinjectdrugs
AT griselnancy novelprogramtoprovidedrugrecoveryassistanceandoutpatientparenteralantibiotictherapyinpeoplewhoinjectdrugs
AT webbbrandonj novelprogramtoprovidedrugrecoveryassistanceandoutpatientparenteralantibiotictherapyinpeoplewhoinjectdrugs